Literature DB >> 6971965

Improved long-term survival following myocardial revascularization in patients with severe left ventricular dysfunction.

J G Coles, C Del Campo, S N Ahmed, R Corpus, A C MacDonald, M M Goldbach, J C Coles.   

Abstract

The natural history of patients with coronary artery disease associated with poor left ventricular (LV) function is dismal. This report analyzes the efficacy of myocardial revascularization in this subset of patients with coronary artery disease manifesting severe LV dysfunction on the basis of LV angiography, LV ejection fraction (LVEF), and left ventricular end-diastolic pressure (LVEDP). For the 2 1/2 year period ending November, 1977, 59 consecutive patients with coronary artery disease complicated by severe LV dysfunction underwent aorta-coronary bypass at the University of Western Ontario. All patients had angina refractory to medical therapy. Objective criteria for compromised LV function included the presence of three or more dysfunctional (hypokinetic of akinetic) segments on biplane LV angiography. Eighty-three percent (49/59) of patients had triple-vessel coronary artery disease. The mean LVEF for the series was 0.28 and the mean LVEDP was 18 mm Hg. The duration of follow-up was 24 to 60 months (mean 37 months), with follow-up survival data available on 100% of patients. The hospital mortality was 1.7% (1/59), and there were nine late deaths. The 5 year actuarial survival rate (+/- SEM) was 80% +/- 6%. Of the 44 long-term survivors available for direct assessment, 98% (43/44) report improvement with respect to angina and 66% (29/44) are totally asymptomatic. Eighty percent (28/35) of the long-term survivors under the age of 65 years are currently employed. These results indicate that myocardial revascularization can be performed in patients with severe ischemic LV dysfunction at very low risk and, further, that operation results in a dramatic improvement in survival expectations compared with optimal medical therapy.

Entities:  

Mesh:

Year:  1981        PMID: 6971965

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

Review 1.  The historical and conceptual evolution of radionuclide assessment of myocardial viability.

Authors:  James E Udelson; Robert O Bonow; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

2.  Prognostic value of persistent thallium-201 defects that become reversible after reinjection in patients with chronic myocardial infarction.

Authors:  A Tisselli; P Pieri; G Moscatelli; M Agostini; O Nanni; A Spinelli; P Riva
Journal:  J Nucl Cardiol       Date:  1997 May-Jun       Impact factor: 5.952

Review 3.  Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction.

Authors:  F A Mitropoulos; J A Elefteriades
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

Review 4.  Hibernating myocardium in patients with coronary artery disease: identification and clinical importance.

Authors:  R Ferrari; G La Canna; R Giubbini; O Alfieri; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

5.  Risk stratification of patients with coronary artery disease and left ventricular dysfunction by exercise radionuclide angiography and exercise electrocardiography.

Authors:  G Mazzotta; L Pace; R O Bonow
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

Review 6.  Prognostic and therapeutic implications of myocardial viability in patients with heart failure.

Authors:  Prem Soman; James E Udelson
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

7.  The role of radionuclide angiocardiography in the preoperative prediction of pain relief and prolonged survival following coronary artery bypass grafting.

Authors:  R H Jones; R D Floyd; E H Austin; D C Sabiston
Journal:  Ann Surg       Date:  1983-06       Impact factor: 12.969

8.  Coronary artery bypass grafting in patients with profound ventricular dysfunction.

Authors:  F J Baumgartner; B O Omari; S Goldberg; A B Pandya; A B Pandya; A M Daland; S Sun; J C Millikin
Journal:  Tex Heart Inst J       Date:  1998

9.  Mitral regurgitation in patients with coronary artery disease and low left ventricular ejection fractions. How should it be treated?

Authors:  J T Christenson; F Simonet; J Maurice; A Bloch; V Velebit; M Schmuziger
Journal:  Tex Heart Inst J       Date:  1995

10.  A comparison of drug-eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure.

Authors:  Kun Wang; Le Wang; Hongliang Cong; Jingxia Zhang; Yuecheng Hu; Yingyi Zhang; Rui Zhang; Wenyu Li; Wei Qi
Journal:  ESC Heart Fail       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.